XDH and ischemia: In addition, research has also demonstrated that the utilization of a xanthine oxidoreductase inhibitor can effectively reduce SUA concentrations and provide safeguarding advantages in scenarios characterized by oxidative stress, such as instances of ischemia–reperfusion injury and cardiovascular disease [54–56].